ALLMedicine™ Autoimmune Hepatitis Center
Research & Reviews 1,070 results
https://doi.org/10.1002/cpt.2423
Clinical Pharmacology and Therapeutics; Cueto-Sanchez A, Niu H et. al.
Sep 21st, 2021 - The identification of specific human leukocyte antigen (HLA) risk alleles in drug-induced liver injury (DILI) points towards an important role of the adaptive immune system in DILI development. In this study we aimed to corroborate the role of an ...
https://doi.org/10.1111/ctr.14479
Clinical Transplantation; Singal AK, Wong RJ et. al.
Sep 13th, 2021 - Data are sparse on etiology specific outcomes on waitlist (WL) and post-transplant outcomes among patients with acute on chronic liver failure (ACLF). In a retrospective cohort of 14,774 adults from United network for organ sharing (UNOS) database...
https://doi.org/10.1111/apt.16574
Alimentary Pharmacology & Therapeutics; Czaja AJ
Sep 11th, 2021 - The B cell activation system, consisting of B cell activating factor and a proliferation-inducing ligand, may have pathogenic effects in autoimmune hepatitis. To describe the biological actions of the B cell activation system, indicate its possibl...
https://doi.org/10.1007/s12016-021-08888-9 10.1038/nrdp.2018.17 10.1016/j.jaut.2012.11.002 10.1111/jgh.14746 10.1016/j.jhep.2015.06.030 10.1002/hep.31065 10.1016/S0016-5085(19)33223-8 10.1016/S0140-6736(73)92125-9 10.1093/oxfordjournals.qjmed.a067264 10.1016/j.jpeds.2019.11.028 10.1016/j.jaut.2018.10.004 10.1016/j.jhep.2004.08.002 10.1016/S0168-8278(20)31423-9 10.1016/j.jhep.2020.07.032 10.1016/S0140-6736(56)91483-0 10.1002/art.1780400909 10.1177/000992280404300709 10.1136/ard.2009.127100 10.1515/cclm-2018-0188 10.1111/j.1572-0241.2006.00479.x 10.1016/j.jaut.2013.08.001 10.1002/jcla.21813 10.1016/j.ejim.2020.02.001 10.3389/fimmu.2018.00609 10.1055/s-0029-1233533 10.3748/wjg.14.3374 10.1016/j.jaut.2018.07.006 10.1007/s004410050718 10.1196/annals.1398.047 10.1016/S0168-8278(99)80297-9 10.1002/hep.22322 10.1007/s13317-016-0075-0 10.1016/S0140-6736(65)92505-5 10.1136/jcp.29.5.403 10.1016/j.ejim.2017.10.006 10.1080/0891693021000054066 10.1002/hep.510260305 10.1002/hep.510240515 10.1136/jcp.2006.039404 10.1136/jcp.2005.027367 10.1097/MPG.0000000000001801 10.1016/j.jaut.2018.10.008 10.1053/jhep.2001.22131 10.1136/bmj.2.5910.80 10.1002/hep.1840070626 10.1007/s12016-014-8427-x 10.1002/hep.510250308 10.1016/0016-5085(92)91518-9 10.1172/JCI113949 10.1073/pnas.85.21.8256 10.1084/jem.168.2.801 10.1136/jcp.55.12.906 10.4049/jimmunol.170.3.1481 10.1172/JCI115443 10.1016/0016-5085(93)90657-X 10.1053/jhep.2002.35339 10.1136/bmjgast-2018-000203 10.1136/gut.37.3.406 10.1111/j.1365-2249.1994.tb06585.x 10.1177/039463200401700112 10.1097/00005176-200406001-00419 10.1016/S0140-6736(97)06478-7 10.1002/hep.1840040223 10.1073/pnas.84.2.551 10.1016/S0016-5085(96)70020-3 10.1016/S0140-6736(94)91966-6 10.1056/NEJM199006283222601 10.1016/S0016-5085(98)70484-6 10.1002/hep.1840080632 10.1016/S0016-5085(99)70186-1 10.1053/jhep.2001.27179 10.1136/gut.36.5.749 10.1186/1740-2557-4-2 10.1016/S0140-6736(87)90443-0 10.1002/hep.1840180102 10.1016/S0140-6736(87)92024-1 10.1053/jhep.2002.32092 10.1016/S0140-6736(00)02166-8 10.1053/jhep.2001.22218 10.1073/pnas.89.20.9739 10.1046/j.1365-2249.2000.01280.x 10.1053/jhep.2002.30699 10.1053/j.gastro.2008.07.029 10.1111/liv.14280 10.1016/S0140-6736(85)91147-X 10.1056/NEJM198806233182504 10.1007/s12016-017-8616-5 10.1002/hep.510280207 10.3748/wjg.14.3781 10.1016/S0168-8278(00)80241-X 10.1046/j.1440-1746.2000.02078.x 10.1136/gut.2008.157818 10.1016/0016-5085(95)90215-5 10.1186/1740-2557-1-2 10.1111/liv.13238 10.1159/000515361 10.1002/hep.21828 10.1002/hep.26666 10.1056/NEJMcpc0807822 10.1038/nrrheum.2017.74
Clinical Reviews in Allergy & Immunology; Terziroli Beretta-Piccoli B, Mieli-Vergani G et. al.
Sep 8th, 2021 - Circulating autoantibodies are a key diagnostic tool in autoimmune hepatitis (AIH), being positive in 95% of the cases if tested according to dedicated guidelines issued by the International Autoimmune Hepatitis Group. They also allow the distinct...
https://doi.org/10.1016/j.jhep.2021.08.024
Journal of Hepatology; Björnsson HK, Gudbjornsson B et. al.
Sep 7th, 2021 - Infliximab has been associated with drug-induced liver injury (DILI), particularly drug-induced autoimmune hepatitis (DIAIH). DIAIH is commonly treated with corticosteroids, but there is limited data on the efficacy of corticosteroids in inflixima...
Guidelines 4 results
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...
https://doi.org/10.1002/hep.31065
Hepatology (Baltimore, Md.); Mack CL, Adams D et. al.
Dec 22nd, 2019 - Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.|2019|Mack CL,Adams D,Assis DN,Kerkar N,Manns MP,|diagnosis,drug therapy,
https://doi.org/10.1038/ajg.2016.517
The American Journal of Gastroenterology; Kwo PY, Cohen SM et. al.
Dec 21st, 2016 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...
https://doi.org/10.1002/hep.23584
Hepatology (Baltimore, Md.); Manns MP, Czaja AJ et. al.
Jun 1st, 2010 - Diagnosis and management of autoimmune hepatitis.|2010|Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,|blood,diagnosis,drug therapy,immunology,pathology,
Drugs 7 results see all →
News 74 results
https://www.medscape.com/viewarticle/954067
Jul 1st, 2021 - Autoimmune hepatitis that recurs following a liver transplant can impair both graft survival and overall survival, results of a large international study showed. Among 736 patients with autoimmune hepatitis who underwent liver transplant and were ...
https://www.medscape.com/viewarticle/945131
Feb 2nd, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...
https://www.medscape.com/viewarticle/930411
May 14th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News
Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.
https://www.reuters.com/article/us-cymabay-nash/cymabay-therapeutics-scraps-two-studies-of-liver-drug-shares-plunge-idUSKBN1XZ1MC
Nov 25th, 2019 - (Reuters) - CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients, sending its shares down over 75%. The drug developer said it had obs...
